15-deoxy-[delta]12,14-prostaglandin J2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficit
Rationale:Fluid shear stress (FSS) maintains NOS-3 (endothelial NO synthase) expression. Homozygosity for the C variant of the T-786C single-nucleotide polymorphism of the NOS3 gene, which solely exists in humans, renders the gene less sensitive to FSS, resulting in a reduced endothelial cell (EC) c...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 Jun 2019
|
| In: |
Circulation research
Year: 2019, Jahrgang: 125, Heft: 3, Pages: 282-294 |
| ISSN: | 1524-4571 |
| DOI: | 10.1161/CIRCRESAHA.118.313820 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1161/CIRCRESAHA.118.313820 Verlag, lizenzpflichtig, Volltext: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313820 |
| Verfasserangaben: | Urban Ivelina, Turinsky Martin, Gehrmann Sviatlana, Morgenstern Jakob, Brune Maik, Milewski Moritz R., Wagner Andreas H., Rumig Cordula, Fleming Thomas, Leuschner Florian, Gleissner Christian A., and Hecker Markus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1695708741 | ||
| 003 | DE-627 | ||
| 005 | 20230426080131.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200422s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCRESAHA.118.313820 |2 doi | |
| 035 | |a (DE-627)1695708741 | ||
| 035 | |a (DE-599)KXP1695708741 | ||
| 035 | |a (OCoLC)1341316404 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Urban, Ivelina |e VerfasserIn |0 (DE-588)1208925431 |0 (DE-627)1696047765 |4 aut | |
| 245 | 1 | 0 | |a 15-deoxy-[delta]12,14-prostaglandin J2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficit |c Urban Ivelina, Turinsky Martin, Gehrmann Sviatlana, Morgenstern Jakob, Brune Maik, Milewski Moritz R., Wagner Andreas H., Rumig Cordula, Fleming Thomas, Leuschner Florian, Gleissner Christian A., and Hecker Markus |
| 246 | 3 | 0 | |a Δ |
| 246 | 3 | 3 | |a 15-deoxy-delta 12,14-prostaglandin J 2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficit |
| 264 | 1 | |c 19 Jun 2019 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Im Titel ist [delta] als griechischer Buchstabe dargestellt | ||
| 500 | |a Im Titel ist die Zahl 2 bei J2 tiefgestellt | ||
| 500 | |a Gesehen am 22.04.2020 | ||
| 520 | |a Rationale:Fluid shear stress (FSS) maintains NOS-3 (endothelial NO synthase) expression. Homozygosity for the C variant of the T-786C single-nucleotide polymorphism of the NOS3 gene, which solely exists in humans, renders the gene less sensitive to FSS, resulting in a reduced endothelial cell (EC) capacity to generate NO. Decreased bioavailability of NO in the arterial vessel wall facilitates atherosclerosis. Consequently, individuals homozygous for the C variant have an increased risk for coronary heart disease (CHD).Objective:At least 2 compensatory mechanisms seem to minimize the deleterious effects of this single-nucleotide polymorphism in affected individuals, one of which is characterized herein.Methods and Results:Human genotyped umbilical vein ECs and THP-1 monocytes were used to investigate the role of 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) in vitro. Its concentration in plasma samples from genotyped patients with CHD and age-matched CHD-free controls was determined using quantitative ultraperformance LC-MS/MS. Exposure of human ECs to FSS effectively reduced monocyte transmigration particularly through monolayers of CC-genotype ECs. Primarily in CC-genotype ECs, FSS elicited a marked rise in COX (cyclooxygenase)-2 and L-PGDS (lipocalin-type prostaglandin D synthase) expression, which appeared to be NO sensitive, and provoked a significant release of 15d-PGJ2 over baseline. Exogenous 15d-PGJ2 significantly reduced monocyte transmigration and exerted a pronounced anti-inflammatory effect on the transmigrated monocytes by downregulating, for example, transcription of the IL (interleukin)-1β gene (IL1B). Reporter gene analyses verified that this effect is due to binding of Nrf2 (nuclear factor [erythroid-derived 2]-like 2) to 2 AREs (antioxidant response elements) in the proximal IL1B promoter. In patients with CHD, 15d-PGJ2 plasma levels were significantly upregulated compared with age-matched CHD-free controls, suggesting that this powerful anti-inflammatory prostanoid is part of an endogenous defence mechanism to counteract CHD.Conclusions:Despite a reduced capacity to form NO, CC-genotype ECs maintain a robust anti-inflammatory phenotype through an enhanced FSS-dependent release of 15d-PGJ2. | ||
| 700 | 1 | |a Turinsky, Martin |e VerfasserIn |0 (DE-588)1208437607 |0 (DE-627)1694686345 |4 aut | |
| 700 | 1 | |a Gehrmann, Sviatlana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Morgenstern, Jakob |d 1985- |e VerfasserIn |0 (DE-588)1129805832 |0 (DE-627)884397599 |0 (DE-576)486560864 |4 aut | |
| 700 | 1 | |a Brune, Maik |d 1974- |e VerfasserIn |0 (DE-588)130611883 |0 (DE-627)504641948 |0 (DE-576)298297930 |4 aut | |
| 700 | 1 | |a Milewski, Moritz R. |d 1995- |e VerfasserIn |0 (DE-588)1208812920 |0 (DE-627)1695708202 |4 aut | |
| 700 | 1 | |a Wagner, Andreas H. |d 1963- |e VerfasserIn |0 (DE-588)1047559080 |0 (DE-627)778552381 |0 (DE-576)401158144 |4 aut | |
| 700 | 1 | |a Rumig, Cordula |e VerfasserIn |0 (DE-588)13295771X |0 (DE-627)529188007 |0 (DE-576)299527808 |4 aut | |
| 700 | 1 | |a Fleming, Thomas |d 1982- |e VerfasserIn |0 (DE-588)1034445294 |0 (DE-627)745607365 |0 (DE-576)382066804 |4 aut | |
| 700 | 1 | |a Leuschner, Florian |e VerfasserIn |0 (DE-588)1072736144 |0 (DE-627)828165742 |0 (DE-576)189305347 |4 aut | |
| 700 | 1 | |a Gleißner, Christian A. |d 1976- |e VerfasserIn |0 (DE-588)124269907 |0 (DE-627)085750522 |0 (DE-576)294095578 |4 aut | |
| 700 | 1 | |a Hecker, Markus |d 1960- |e VerfasserIn |0 (DE-588)1071693344 |0 (DE-627)826266037 |0 (DE-576)433260319 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation research |d New York, NY : Assoc., 1953 |g 125(2019), 3, Seite 282-294 |h Online-Ressource |w (DE-627)266880126 |w (DE-600)1467838-X |w (DE-576)075145766 |x 1524-4571 |7 nnas |a 15-deoxy-[delta]12,14-prostaglandin J2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficit |
| 773 | 1 | 8 | |g volume:125 |g year:2019 |g number:3 |g pages:282-294 |g extent:13 |a 15-deoxy-[delta]12,14-prostaglandin J2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficit |
| 856 | 4 | 0 | |u https://doi.org/10.1161/CIRCRESAHA.118.313820 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313820 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200422 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1071693344 |a Hecker, Markus |m 1071693344:Hecker, Markus |d 50000 |d 53200 |e 50000PH1071693344 |e 53200PH1071693344 |k 0/50000/ |k 1/50000/53200/ |p 12 | ||
| 998 | |g 124269907 |a Gleißner, Christian A. |m 124269907:Gleißner, Christian A. |d 50000 |e 50000PG124269907 |k 0/50000/ |p 11 | ||
| 998 | |g 1072736144 |a Leuschner, Florian |m 1072736144:Leuschner, Florian |d 910000 |d 910100 |e 910000PL1072736144 |e 910100PL1072736144 |k 0/910000/ |k 1/910000/910100/ |p 10 | ||
| 998 | |g 1034445294 |a Fleming, Thomas |m 1034445294:Fleming, Thomas |d 910000 |d 910100 |e 910000PF1034445294 |e 910100PF1034445294 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 998 | |g 13295771X |a Rumig, Cordula |m 13295771X:Rumig, Cordula |d 50000 |d 53200 |e 50000PR13295771X |e 53200PR13295771X |k 0/50000/ |k 1/50000/53200/ |p 8 | ||
| 998 | |g 1208812920 |a Milewski, Moritz R. |m 1208812920:Milewski, Moritz R. |d 50000 |e 50000PM1208812920 |k 0/50000/ |p 6 | ||
| 998 | |g 1047559080 |a Wagner, Andreas H. |m 1047559080:Wagner, Andreas H. |d 50000 |d 53200 |e 50000PW1047559080 |e 53200PW1047559080 |k 0/50000/ |k 1/50000/53200/ |p 7 | ||
| 998 | |g 130611883 |a Brune, Maik |m 130611883:Brune, Maik |d 910000 |d 910100 |e 910000PB130611883 |e 910100PB130611883 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1208437607 |a Turinsky, Martin |m 1208437607:Turinsky, Martin |d 910000 |d 910500 |e 910000PT1208437607 |e 910500PT1208437607 |k 0/910000/ |k 1/910000/910500/ |p 2 | ||
| 998 | |g 1129805832 |a Morgenstern, Jakob |m 1129805832:Morgenstern, Jakob |d 910000 |d 910100 |e 910000PM1129805832 |e 910100PM1129805832 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 999 | |a KXP-PPN1695708741 |e 3630161995 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Urban Ivelina, Turinsky Martin, Gehrmann Sviatlana, Morgenstern Jakob, Brune Maik, Milewski Moritz R., Wagner Andreas H., Rumig Cordula, Fleming Thomas, Leuschner Florian, Gleissner Christian A., and Hecker Markus"]},"physDesc":[{"extent":"13 S."}],"recId":"1695708741","relHost":[{"id":{"eki":["266880126"],"issn":["1524-4571"],"zdb":["1467838-X"]},"recId":"266880126","pubHistory":["1.1953 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"part":{"volume":"125","extent":"13","text":"125(2019), 3, Seite 282-294","pages":"282-294","year":"2019","issue":"3"},"note":["Gesehen am 09.08.2019"],"origin":[{"publisherPlace":"New York, NY","dateIssuedDisp":"1953-","publisher":"Assoc.","dateIssuedKey":"1953"}],"title":[{"subtitle":"an official journal of the American Heart Association","title_sort":"Circulation research","title":"Circulation research"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"15-deoxy-[delta]12,14-prostaglandin J2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficitCirculation research","corporate":[{"display":"American Heart Association","role":"isb"}]}],"id":{"doi":["10.1161/CIRCRESAHA.118.313820"],"eki":["1695708741"]},"person":[{"role":"aut","given":"Ivelina","family":"Urban","display":"Urban, Ivelina"},{"family":"Turinsky","display":"Turinsky, Martin","given":"Martin","role":"aut"},{"given":"Sviatlana","role":"aut","family":"Gehrmann","display":"Gehrmann, Sviatlana"},{"role":"aut","given":"Jakob","display":"Morgenstern, Jakob","family":"Morgenstern"},{"given":"Maik","role":"aut","family":"Brune","display":"Brune, Maik"},{"family":"Milewski","display":"Milewski, Moritz R.","given":"Moritz R.","role":"aut"},{"role":"aut","given":"Andreas H.","display":"Wagner, Andreas H.","family":"Wagner"},{"family":"Rumig","display":"Rumig, Cordula","role":"aut","given":"Cordula"},{"given":"Thomas","role":"aut","family":"Fleming","display":"Fleming, Thomas"},{"role":"aut","given":"Florian","family":"Leuschner","display":"Leuschner, Florian"},{"family":"Gleißner","display":"Gleißner, Christian A.","role":"aut","given":"Christian A."},{"given":"Markus","role":"aut","display":"Hecker, Markus","family":"Hecker"}],"note":["Im Titel ist [delta] als griechischer Buchstabe dargestellt","Im Titel ist die Zahl 2 bei J2 tiefgestellt","Gesehen am 22.04.2020"],"origin":[{"dateIssuedDisp":"19 Jun 2019","dateIssuedKey":"2019"}],"title":[{"title_sort":"15-deoxy-[delta]12,14-prostaglandin J2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficit","title":"15-deoxy-[delta]12,14-prostaglandin J2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficit"}],"titleAlt":[{"title":"15-deoxy-delta 12,14-prostaglandin J 2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficit"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} | ||
| SRT | |a URBANIVELI15DEOXYDEL1920 | ||